Impaired paracrine effect of endothelin-1 on vascular smooth muscle in streptozotocin-diabetic: Rats

Cardiovascular Research

Volumn 39, Issue 3, 1998, Pages 651-656

  Wu, Sheng Qian ^a   Tang, Fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes; Endothelin; Paracrine; Rat; Receptors; Vascular smooth muscle

Indexed keywords

ENDOTHELIN 1; INSULIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BLOTTING, SOUTHERN; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENDOTHELINS; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PARACRINE COMMUNICATION; PROTEIN BINDING; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032168269     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00176-X     Document Type: Article

References (27)

1. Yanagisawa M., Kurihare H., Kimura S.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature Lond. 332:1988;411-415.
2. Rubanyi G.M., Polokoff M.A. Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev. 46(3):1994;325-415.
3. Warner T.D., Mitchell J.A., De Nucci G., Vana J.R. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol. 13:1989;S85-S88.
4. Collier A., Leach J.P., McLellan A., Jardine A., Morton J.J., Small M. Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuia. Diabetes Care. 15:1992;1038-1040.
5. Takeda Y., Miyamori I., Yoneda T., Takeda R. Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. Life Sci. 48:1991;2553-2556.
6. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
7. Totsune K., Sone M., Takahashi K.et al. Immunoreactive endothelin in urine of patients with and without diabetes mellitus. J Cardiovasc Pharmacol. 17(Suppl. 7):1991;S423-S424.
8. Kanno K., Hirata Y., Shichiri M., Marumo F. Plasma endothelin 1 levels in patients with diabetes mellitus with or without vascular complication. J Cardiovasc Pharmacol. 17(Suppl.7):1991;S474-S476.
9. Tsunoda K., Abe K., Sato T., Yokosawa S., Yoshinaga K. Decreased conversion of big endothelin 1 to endothelin 1 in patients with diabetes mellitus. Clin Exp Pharmacol Physiol. 18:1991;731-732.
10. Takahashi K., Suda K., Lam H.C., Ghatei M.A., Bloom S.R. Endothelin-like immunoreactivity in rat models of diabetes mellitus. J Endocrinol. 130:1991;123-127.
11. Taylor P.D., McCarthy A.L., Thomas C.R., Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol. 107:1992;393-399.
12. Taylor P.D., Wickenden A.D., Mirrlees D.J., Poston L. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmacol. 111:1994;42-48.
13. Ozturk Y., Altan V.M., Yildizoglu-Ari N. Effect of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev. 48:1996;69-112.
14. 2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 104:1991;928-932.
15. Hodgson W.C., King R.G. Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin 1 of aortic rings from streptozotocin induced diabetic rats. Br J Pharmacol. 106:1991;644-649.
16. Awazu M., Parker R.E., Harvie B.R., Ichikawa I., Kon V. Downregulation of endothelin 1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol. 17(Suppl. 7):1991;S500-S502.
17. 125I]-endothelin binding sites in rat cardiac membranes. Br J Pharmacol. 97:1989;993-995.
18. Wagner O.F., Christ G., Wojta J.et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 267:1992;16066-16068.
19. Filep J.G. Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension. 30:1997;22-28.
20. Wu S.Q., Kwan C.Y., Tang F. The effect of aging on ANP levels in the plasma, heart and brain of rats. J Gerontol. 52A(5):1997;B250-B254.
21. Sakurai T., Yanagisawa M., Inoue A.et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun. 175:1991;44-47.
22. Yamuchi T., Ohnaka K., Takayanagi R., Umeda F., Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 267:1990;16-18.
23. Hattori Y., Kasai K., Nakamura T., Emoto T., Shimoda S. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism. 40:1991;165-169.
24. Kaasjager K.A.H., Koomans H.A., Rabelink T.J. Endothelin-1-induced vasopressor responses in essential hypertension. Hypertension. 30:1997;15-21.
25. Shetty S.S., Okada T., Webb R.L., DelGrande D., Lappe R.W. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun. 191:1993;459-464.
26. A receptor activation. Am J Physiol. 264:1993;R222-R226.
27. Kiff R.J., Gardiner S.M., Compton A.M., Bennett T. The effects of endothelin 1 and NG nitro L arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin induced diabetes mellitus. Br J Pharmacol. 103:1991;1321-1326.